Replimune Group Inc
REPL
Market Cap$724.61M
Close$
$0.43
95.4% downside
Current Fair Value
95.4% downsideOvervalued by 95.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $724.61 Million |
|---|---|
| Enterprise Value | $240.81 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.07 |
| Beta | 0.61 |
| Outstanding Shares | 80,564,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.06 |
|---|---|
| PEG | -8.85 |
| Price to Sales | - |
| Price to Book Ratio | 1.87 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.91 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Replimune Group Inc
CEO: Robert Coffin